Vaccine Overview
Recombinant Human Erythropoietin (rHuEPO) Injection
This biologic is a synthetic form of the human hormone erythropoietin, crucial for red blood cell production. It's used to manage anemia due to chronic renal failure, cancer therapy, or other conditions affecting erythropoiesis. The injection helps restore normal hemoglobin levels and reduces the need for blood transfusions. It is administered under medical supervision, either intravenously or subcutaneously, with dosage adjusted based on patient response, hemoglobin levels, and overall treatment goals.
Drug Class: Recombinant and other Products
Indication: Used for the treatment of anemia, particularly in chronic renal failure, chemotherapy-induced anemia, and anemia from certain medical conditions like HIV/AIDS
PREVENTS
Vaccine Details
Applied To
Infants, Children, Adolescents, Adults
Recommended Time
As prescribed during clinical need
Administration
Route: Subcutaneous (SC) or Intravenous (IV)
Site: Upper arm, abdomen, or thigh (SC); vein (IV)
Disease
Anemia (various causes)
Manufacturer
Serum Intitute Of India
Age
- All age groups
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025